Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Lurasidone Hydrochloride Tablets

Approval Number

国药准字H20243106

Company重庆药友制药有限责任公司

Registration Date

January 30, 2024

Drug Information

Generic Name

盐酸鲁拉西酮片

Dosage Form

片剂

Strength

40mg（按C₂₈H₃₆N₄O₂S·HCl计）

Drug Type

化学药品

Registration Date

January 30, 2024

Company Information

Applicant Company

Company Name重庆药友制药有限责任公司

Company Address

重庆市渝北区人和镇星光大道100号

Manufacturing Company

Company Name重庆药友制药有限责任公司

Company Address

重庆市渝北区人和镇星光大道100号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

盐酸鲁拉西酮片 - NMPA 批准文号 | MedPath